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Plasmids have become very important as pharmaceutical gene vectors in the fields of 
gene therapy and genetic vaccination in the past years. In this study, we present a dynamic 
model to simulate the ColE1-like plasmid replication control, once for a DH5α-strain 
carrying a low copy plasmid (DH5α-pSUP 201-3) and once for a DH5α-strain carrying 
a high copy plasmid (DH5α-pCMV-lacZ) by using ordinary differential equations and the 
MATLAB software. The model includes the plasmid replication control by two regulatory 
RNA molecules (RNAI and RNAII) as well as the replication control by uncharged tRNA 
molecules. To validate the model, experimental data like RNAI- and RNAII concentration, 
plasmid copy number (PCN), and growth rate for three different time points in the expo-
nential phase were determined. Depending on the sampled time point, the measured 
RNAI- and RNAII concentrations for DH5α-pSUP 201-3 reside between 6 ± 0.7 and 
34 ± 7 RNAI molecules per cell and 0.44 ± 0.1 and 3 ± 0.9 RNAII molecules per cell. 
The determined PCNs averaged between 46 ± 26 and 48 ± 30 plasmids per cell. The 
experimentally determined data for DH5α-pCMV-lacZ reside between 345 ± 203 and 
1086 ± 298 RNAI molecules per cell and 22 ± 2 and 75 ± 10 RNAII molecules per cell 
with an averaged PCN of 1514 ± 1301 and 5806 ± 4828 depending on the measured 
time point. As the model was shown to be consistent with the experimentally determined 
data, measured at three different time points within the growth of the same strain, we 
performed predictive simulations concerning the effect of uncharged tRNA molecules on 
the ColE1-like plasmid replication control. The hypothesis is that these tRNA molecules 
would have an enhancing effect on the plasmid production. The in silico analysis predicts 
that uncharged tRNA molecules would indeed increase the plasmid DNA production.
Keywords: plasmid replication, small rna, modeling, ordinary differential equations, uncharged trna, high copy 
plasmid, biotechnology
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introduction
Since the finding that genetically engineered DNA can be used for 
gene therapy and DNA vaccination in the early 90s last century, 
the interest in plasmid DNA (pDNA) as a pharmaceutical gene 
vector has increased constantly (Kutzler and Weiner, 2008). The 
investigation of DNA vaccination in the past years shows entic-
ing results in several areas, especially in prophylactic vaccine 
strategies and the usage of pDNA as potential therapeutics for 
the treatment of infectious diseases, cancer, Alzheimer disease, 
and allergies (Kutzler and Weiner, 2008; Mairhofer and Lara, 
2014). A very promising field of application might be the genetic 
vaccination with DNA molecules to induce an immune response 
(Schleef and Blaesen, 2009). Using DNA molecules in that field 
has the advantage that there are no safety concerns associated 
with live vaccines. Additionally, the manufacturing process is 
short and stable in contrast to conventional vaccines (Kutzler and 
Weiner, 2008; Lara and Ramírez, 2012). It is expected that, since 
DNA vaccines and non-viral gene therapies enter phase 3 clinical 
trials and are approved for utilization, the demand for pDNA will 
increase (Bower and Prather, 2009). To meet these requirements, 
industrial-scale production processes of pDNA with adequate 
bacterial strains and vectors have to be designed. Therefore, it 
is important to understand which factors influence the plasmid 
replication.
In this work, we present a mathematical model to simulate 
the regulation of ColE1-like plasmid replication. Bacterial 
plasmids control their copy number through negative regulatory 
feedback mechanisms that adjust the replication rate (del Solar 
and Espinosa, 2000). In the case of ColE1-like plasmids, the 
replication is controlled by an antisense RNA molecule, which 
inhibits the maturation of the necessary primer RNA molecule 
for the DNA polymerase I (Grabherr and Bayer, 2002). When 
replication occurs, a part of an RNA preprimer transcript, named 
RNAII, binds to the plasmid origin of replication (oriV), where 
it forms a persistent hybrid (Itoh and Tomizawa, 1980). In the 
next step, it must be cleaved by the enzyme RNase H, which is 
specific for DNA–RNA hybrids (Schumann, 2001). This cleav-
age is essential to release the 3’OH group, so that the elongation 
by DNA polymerase I can start (Itoh and Tomizawa, 1980). To 
prevent the replication, this modification of RNAII by RNase 
H can be blocked through binding of a small complementary 
RNA transcript, named RNAI, which is the specific inhibitor of 
primer formation (Tomizawa and Itoh, 1981). RNAI and RNAII 
are coded within the same DNA region that is part of the oriV 
(Tomizawa, 1984). RNAI is constitutively transcribed from the 
opposite strand and regulates the frequency of replication initia-
tion (Tomizawa, 1984). RNAI and RNAII form a transient, the 
so-called “kissing complex,” thus the RNase H cannot modify 
the RNA preprimer transcript anymore (Tomizawa, 1984, 1985). 
This complex is stabilized by the binding of the Rom protein 
(also called Rop protein) (Tomizawa, 1986, 1990). Additionally, 
the plasmid replication control can be affected by starvation 
conditions, which leads to a drop in free amino acids, and 
thus to an increase of uncharged tRNA molecules (Yavachev 
and Ivanov, 1988). If an uncharged tRNA molecule binds to an 
RNAI or RNAII molecule, no kissing complex can be built and 
the RNAII transcript can serve as a preprimer (Grabherr and 
Bayer, 2002). Consequently, a high amount of uncharged tRNA 
molecules is correlated with an increase in plasmid copy number 
(PCN) (Wróbel and Węgrzyn, 1998). Two models are proposed 
to describe the interaction between uncharged tRNA molecules 
and the regulatory RNA molecules. Yavachev and Ivanov (1988) 
found structural and sequence similarities between the loops of 
RNAI, respectively, RNAII and the cloverleaf structure of certain 
tRNA molecules. The second model was introduced by Wang 
et al. (2002), who suggest that the binding between an uncharged 
tRNA molecule and one of the regulatory RNA molecules takes 
place at the amino acid binding site. Although there are kinetic 
models, which explain the regulation of the ColE1-like plasmid 
replication (Ataai and Shuler, 1986; Bremer and Lin-Chao, 1986; 
Keasling and Palsson, 1989a,b; Brendel and Perelson, 1993; Wang 
et al., 2002), these models consider only parts of the ColE1-like 
plasmid replication control. Brendel and Perelson (1993), for 
instance, describe a model for the in  vivo replication control 
mechanism by the regulatory RNA molecules, which includes 
kinetic information and accounts for measured concentration 
values.
In this study, the model proposed by Brendel and Perelson was 
extended. Their model describes the ColE1-like plasmid replica-
tion control by RNAI and RNAII molecules, with or without the 
interaction of Rom protein. They investigated plasmid concentra-
tions at two different growth rates and showed a decrease of the 
PCN in presence of an intact rom gene as well as an increase of 
plasmid production at low growth rates (Brendel and Perelson, 
1993). Apart from the replication control by the two regulatory 
RNA molecules, the plasmid replication can be influenced by 
uncharged tRNA molecules under amino acid starvation condi-
tions (Wróbel and Węgrzyn, 1998). The mathematical model pro-
posed in the present study incorporates the ColE1-like plasmid 
replication control by RNAI and RNAII molecules with or without 
the Rom protein. Additionally, the regulation by uncharged tRNA 
molecules is described. The advantage of this model is that it is 
confirmed by in vitro measurements of the plasmid concentra-
tion at different time points and the appropriate growth rates. 
Additionally, the free intracellular RNAI and RNAII concentra-
tions were determined via quantitative reverse transcription 
real-time-PCR (qRT-PCR) for the same time points. With these 
data, the model was fitted and validated, so it could be used for 
in  silico analysis of the ColE1-like plasmid replication control. 
Since this model takes into account the regulation by modified 
tRNA molecules, which cannot be charged by amino-acyl-tRNA 
synthetases anymore, it is possible to investigate the effect on the 
ColE1-like plasmid replication control.
Materials and Methods
Bacterial strain and Plasmids
The Escherichia coli strain DH5α (F–Φ80lacZΔM15 Δ(lacZYA-
argF) U169 recA1 endA1 hsdR17 (rK−, mK+) phoA supE44 
λ− thi-1 gyrA96 relA1) (Source: Plasmid Factory, Bielefeld, 
Germany) was used as a host strain for transformation of the 
high copy plasmid pCMV-lacZ (Source: Plasmid Factory, 
Bielefeld, Germany) as well as the low copy plasmid pSUP 201-3 
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(Simon et al., 1983). pCMV-lacZ is a ColE1-derived high copy 
plasmid for therapeutic pDNA production with a size of 7164 bp. 
It contains a pBR322 origin of replication without the rom gene 
and carries genetic elements for DNA vaccination together with 
the ampicillin-resistance gene bla. The low copy plasmid pSUP 
201-3 is also a ColE1-derivative and has a size of 7896 bp. It con-
tains a pBR322 origin of replication together with the rom gene 
and carries a specific recognition site for mobilization. For selec-
tion, the ampicillin-resistance gene bla and a chloramphenicol 
resistance gene are located on pSUP 201-3.
cultivation
The cultivation started under aerobic conditions with a pre-cul-
ture in a shaker at 37°C and 300 rpm in LB medium (Invitrogen, 
Darmstadt, Germany). Then, the cells were transferred to a 
synthetic minimal medium (prepared according to Lara et  al., 
2008). The medium consists of: 5 g·L−1 Glucose, 17 g·L−1 K2HPO4, 
5.3  g·L−1·KH2PO4, 2.5  g·L−1 (NH4)2SO4, 1  g·L−1 NH4Cl, 1  g·L−1 
NaCl, 0.01 g·L−1 Thiamine hydrochloride, 1 g·L−1·MgSO4·7H2O, 
and 1 mL L−1 trace elements solution. The trace elements solu-
tion contains: 17 g·L−1·Zn(CH3COO)2·2H2O, 7 g·L−1 Na·EDTA, 
1.25  g·L−1 CoCl2·6H2O, 7.5  g·L−1 MnCl2·4H2O, 0.75  g·L−1 
CuCl2·2H2O, 1.5  g·L−1 H3BO3, 1.05  g·L−1 Na2MoO4·2H2O, 
50  g·L−1 Fe(III) citrate. All chemicals were purchased from 
Sigma-Aldrich (Seelze, Germany), Roth (Karlsruhe, Germany), 
VWR (Darmstadt, Germany), Merck (Darmstadt, Germany), 
Fluka (Seelze, Germany), and Serva (Heidelberg, Germany). No 
ampicillin was added in order to avoid antibiotic stress influence 
on the plasmid production. During the cultivation, samples were 
successively taken, the cells were harvested by centrifugation 
(1 mL culture at 10,000 × g), then the supernatant was removed 
and the pellet was frozen in liquid nitrogen for 10 min and after-
wards stored at −80°C. This was done for three different time 
points during the exponential phase of the cultivation, since we 
are interested in replication during cultivation. Three biological 
replicates were taken at each time point. Samples taken during 
the exponential growth phase are assumed to represent a quasi 
steady state of the metabolism and plasmid replication and the 
most representative phase of a pDNA batch production process.
growth rate Determination
For growth rate determination at all measured time points, the 
cells were cultured in minimal medium and the optical density 
at 600 nm was measured. Growth curves were generated, where 
the optical density data as the natural logarithm of the measured 
OD600 values are given on the y-axis, normalized to the initial 
OD600 value, and the time is given on the x-axis. These growth 
curves were fitted applying the Matlab function “polyfit.” This 
function p finds the coefficients of a polynomial p(x) of degree n 
that fits the optical density data stored in a vector y best in a least-
squares sense, where p is a row vector of length n + 1 containing 
the polynomial coefficients in descending powers, p(1)*x^n +   
p(2)*x^(n – 1) + … + p(n)*x + p(n + 1). Afterwards a χ2-test was 
applied to test the quality of the fit. The successfully fitted growth 
curves are shown in Figures 1 and 2.
In the next step, the first derivative p′(x), which enables the 
calculation of the growth rate for every time point, was generated.
Determination of the rnai and rnaii 
concentrations
To determine the concentrations of RNAI and RNAII, an 
internal standard for each of them was synthesized. Therefore, a 
primer with a T7 RNA polymerase promoter region extension, 
one for the rnaI gene and one for the rnaII gene (Table 1), was 
designed and a PCR amplification was used to amplify double 
strand RNAI- and RNAII-DNA. The PCR mixture with a final 
volume of 25 μL contained 2.5 μL GoTaq reaction buffer, 1.5 μL 
deoxynucleotides (0.2 mM final concentration), 0.5 μL forward 
primer and 0.5 μL reverse primer (each with a final concentration 
of 10 pmol μL−1), 0.75 μL MgCl2 (final concentration of 1.5 mM), 
1 μL GoTaq DNA Polymerase, 0.5 μL pDNA, and nuclease-free 
water to fill up to 25  μL. All chemicals were obtained from 
Promega (Mannheim, Germany) except the PCR primers, which 
were purchased from Metabion (Martinsried, Germany). The 
PCR was performed in a MJ Research PTC-100 Programmable 
Thermal Controller from Lab Recyclers (Gaithersburg, USA) 
applying the following program: an activation step for the hot 
start Taq polymerase was carried out at 94°C for 2 min, followed 
by an initial denaturation step at 94°C for 30  s, an annealing 
step at 64°C for RNAI (67°C for RNAII) and an extension step 
at 72°C for 20  s. This cycle was repeated 30 times and ended 
with a final extension step at 72°C for 2 min. The PCR product 
was purified using the NucleoSpin Extract II Kit from Macherey-
Nagel (Düren, Germany) and the concentration was measured 
spectrophotometrically (NanoDrop2000c spectrometer, Thermo 
Scientific, Braunschweig, Germany). The PCR product was used 
as a template for the T7 RNA polymerase (Roche, Mannheim, 
Germany) according to the manufacturer’s instructions to 
synthesize RNA. The reaction mixture with a final volume of 
20 μL contained 1 mM of each nucleotide (NTP), 2 μL supplied 
buffer (10×), 40 U T7 RNA polymerase, 20 U Ribolock RNase 
inhibitor, 1 μg template DNA, and DEPC-treated water to fill 
up to 20 μL. The mixture was incubated for 2  h at 37°C. The 
residual template DNA was digested by adding 2 μL DNaseI and 
incubated 15  min at 37°C. All chemicals were obtained from 
Fermentas (Schwerte, Germany). The inactivation was done 
by lithium chloride (LiCl)-precipitation using the following 
protocol: 2.5 μL LiCl (4M) were added to the 20 μL reaction 
mixture; in the next step, 75 μL ethanol (>99%) were added. 
Then, the RNA was precipitated for 30 min at −80°C. After that, 
for pelleting the RNA, the samples were centrifuged for 15 min 
at 4°C with 13,000  rpm. The supernatant was discarded and 
the pellet was washed with 200  μL ethanol (70%). After that 
it was centrifuged for 15 min at 4°C with 13,000 rpm and the 
supernatant was discarded. The washing procedure was repeated 
and after discarding the supernatant, the pellet was dried until 
the residual ethanol was evaporated. In the last step, the pellet 
was dissolved in 20 μL nuclease-free water. For generating a cali-
bration for RNAI, a 10-fold serial dilution series ranging from 
2 × 10−1 to 2 × 10−6 ng μL−1 was made and analyzed via qRT-PCR. 
A calibration curve was generated by plotting the cycle threshold 
values (CT-values) against the time. For the RNAII standard 
curve, the same procedure was applied. Only the range for the 
measured 10-fold serial dilution series was different: 2 × 10−1to 
2 × 10−7 ng μL−1.
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For sampling the RNA I and RNA II content, cells were 
cultivated as described above and harvested at each time point. 
Before harvesting, a dilution series was generated. For different 
dilutions, 50 μL per sample were plated to determine the cell titer. 
After doing this, 1 mL of the cell culture was harvested and cen-
trifuged. Then, the supernatant was removed and the pellet was 
frozen in liquid nitrogen for 10 min and then stored at −80°C. 
Lysing Matrix B tubes (MP Biomedicals, Heidelberg, Germany) 
were prepared with 700 μL RLT buffer (RNeasy Plus Mini Kit, 
Qiagen, Hilden, Germany) with 7 μL β-mercaptoethanol. The 
filled tubes were incubated on ice for 5 min. The pellet was re-
suspended in 200 μL 10 mM Tris-HCl, pH 8, and added to the 
prepared ice-cold tubes. The cells were lysed using the Hybaid 
ribolyser for 30 s, level 6.5 m s−1, and then incubated on ice for 
3  min. After centrifugation at 13,000  rpm and 4°C for 3  min, 
the supernatant was transferred into a new RNase free reac-
tion tube. The centrifugation step was repeated and again the 
supernatant was transferred onto the gDNA Eliminator spin 
column and centrifuged twice at 10,000 rpm, 4°C, and 30 s. The 
flow through was transferred into a new RNase free reaction 
tube. The next steps of RNA isolation were performed using the 
RNeasy Plus Mini Kit (Qiagen, Hilden Germany) according to 
the protocol Appendix D, starting at step D3 to step D8, with 
the modification that after step D6 an additional washing step 
with 500 μL ethanol (80%) was performed. The isolated RNA 
was measured via quantitative reverse transcription real-time 
FigUre 1 | growth curve for E. coli Dh5α-psUP 201-3. The growth curve 
based on OD600 measurements are marked by black circles and the appropriate 
best-fit curve is indicated in blue. The harvesting time points T1, T2, and T3 are 
presented as bold big points. The minimum–maximum area, within which the 
measurement values have to reside, is bordered by the red curve (minimal 
measured OD600 values) and the green curve (maximal measured OD600 values).
PCR (qRT-PCR) using the Sensi-Mix SYBR No-Rox One Step 
Kit (Bioline, Luckenwalde, Germany). The reaction mixture was 
prepared according to the proposed protocol with the modi-
fication that the reverse transcription was done with only one 
primer (RNAI-reverse and RNAII-reverse). The second primer 
was added just before the beginning of the PCR. As the RNAI 
molecule is an antisense RNA to the RNAII molecule, we had to 
stick to our modified protocol in order to avoid that the respec-
tive forward primer would bind to both RNA molecules. In this 
case, both RNA molecules would be reversely transcribed and 
we would not be able to determine the absolute amount of the 
particular molecule by PCR. Table 2 shows the used primer sets. 
The reverse transcription reaction was done in the PCR thermo 
cycler machine (MJ Research PTC-100 Programmable Thermal 
Controller from Lab Recyclers, Gaithersburg, MD, USA) at 42°C 
for 10 min. All real-time-PCR experiments were performed using 
the Opticon machine (BioRad, München, Germany) according 
to the following protocol: 10  min at 95°C initial polymerase 
activation step, 40 cycles [15 s at 95°C, annealing 15 s at 61°C 
(for RNAI), respectively, 56°C (for RNAII), 15 s at 72°C elonga-
tion]. A reaction mixture with a final volume of 20 μL contain-
ing 6.2 μL DEPC-treated H2O, 10.8 μL Sensi-Mix, 1 μL Primer 
(RNAI-reverse primer respectively RNAII-reverse primer), and 
1 μL RNA was used. After having run the reverse transcription, 
1  μL of the second primer was added and the qRT-PCR was 
started. After each PCR-cycle, the fluorescence was measured for 
TaBle 1 | Primer sequences to generate internal rnai and rnaii 
standards.
Target Orientation Primer (5′–3′) length 
[nt]
rnaI Forward GAAATTAATACGACTCACTATAGG 
GACAGTATTTGGTATCTGCGCTC
47
Reverse AACCACCGCTACCAGCGG 18
rnaII Forward GAAATTAATACGACTCACTATAGGG 
GCAAACAAAAAAACCACCGCTACCA
50
Reverse TTTCCATAGGCTCCGCCCCC 20
TaBle 2 | Primer sequences to determine the rnai and rnaii amount 
via qrT-Pcr.
Target Orientation Primer (5′–3′) length [nt]
rnaI Forward TTGGTATCTGCGCTCTGC 18
Reverse CAGCGGTGGTTTGTTTGC 18
rnaII Forward TAACTGGCTTCAGCA 
GAGCGCAGAT
25
Reverse CCTGCCGCTTACCG 
GATACCTGT
23
FigUre 2 | growth curve for E. coli Dh5α-pcMV-lacZ. The growth 
curve based on OD600 measurements is marked by small black  
circles and the appropriate best-fit curve is indicated in blue. The 
harvesting time points T1, T2, and T3 are presented as bold big points.  
The minimum–maximum area, within which the measurement  
values have to reside, is bordered by the red curve (minimal  
measured OD600 value) and the green curve (maximal measured  
OD600 value).
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all PCR products. The raw data analysis was carried out with the 
corresponding Opticon monitor software. Different dilutions of 
the internal RNA standards were determined via qRT-PCR and 
the CT-values were calculated. Then the CT-values were plotted 
against the number of RNA molecules and straight calibration 
lines for RNAI and RNAII was generated. CT-values were deter-
mined as mentioned above for DH5α-low copy RNA samples 
and DH5α-high copy RNA samples and the appropriate absolute 
RNA concentration was calculated with the help of the linear 
regression curve. Then, the RNA amount per cell was calculated 
for each sample in mol per liter. These values were subsequently 
used for the theoretical model.
Determination of the Plasmid Dna 
concentrations
The determination of the pDNA concentrations was done by 
the company Plasmid Factory GmbH & Co. KG (Bielefeld, 
Germany). The plasmids were isolated by the Plasmid Factory 
GmbH & Co. KG (Bielefeld, Germany) with a NucleoBond 
PC20 kit from Macherey-Nagel (Düren, Germany) and the 
amount of purified pDNA was measured photometrically at the 
wavelength of 260  nm. Subsequently, the isolated pDNA was 
separated by agarose gel electrophoresis to check for possible 
contamination by chromosomal DNA. In case of contamina-
tions, the ratio of chromosomal DNA to pDNA was determined 
c1
stable RNA I - RNA II
RNA I - RNA II - Rom
pDNA - RNA II-s
unstable RNA I - RNA II
pDNA - RNA II-lo
pDNA - RNA II - tRNA
pDNA - RNA II Primer
tRNA - RNA II
Rom
RNA I
Rom
RNA II
RNA I
RNA II
Rom
RNA I
pDNA
RNA II-lo
RNA II
tRNA
RNA II-lo
pDNA
RNA II
pDNA
RNA I
RNA II
RNA I
Rom
pDNA
pDNA
RNA II
RNA II
pDNA
RNA I
pDNA
RNA II-lo
tRNA
pDNA
RNA II
pDNA
RNA II Primer
tRNA
RNA II
FigUre 3 | structural model of cole1-like plasmid replication control 
for low and high copy plasmids as outlined by the cellDesigner 
software. The structural model represents an extension of the model proposed 
by Brendel and Perelson (1993) for ColE1-like plasmid replication control (the 
corresponding reactions are surrounded by the blue box). The difference 
between the description of the replication control for a low copy plasmid and 
for a high copy plasmid is three additional reactions (shown in the red box). 
These reactions describe the control by the Rom protein and are not active in a 
high copy plasmid. The reactions outside of the blue box were added within 
this work and describe the replication control by uncharged tRNA molecules.
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densitometrically using the software LabImage 1D L 340 (Intas 
Science Imaging GmbH). With this ratio, the amount of pure 
pDNA in the entire isolated pDNA sample could be determined 
and with the previously determined cell titers the absolute 
plasmid concentration in PCN for each harvesting time point 
was calculated. All measurements were carried out with three 
biological replicates.
The Theoretical Model
The modeling work started with building a structural model to 
visualize all relevant components and their interactions involved 
in ColE1-like plasmid replication control. This was done using the 
CellDesigner software (Ver. 4.1) (Funahashi et al., 2008), in which 
the replication control of low copy and high copy plasmids are 
described simultaneously (Figure 3). Note that during low copy 
plasmid control, three additional reactions representing the Rom 
protein control are involved. These reactions [see rate equations 
v1, v2, and v13 in the ordinary differential equation (ODE) system] 
are marked with a red box in Figure 3 and describe the regulation 
by the Rom protein, which does not take place in strains carrying 
the high copy plasmid, due to deletion of the rom gene (Yanisch-
Perron et al., 1985; Lin-Chao et al., 1992). As mentioned before, 
this model is an extension of the model presented by Brendel and 
Perelson (1993), the reactions which originated from their model 
are marked with a blue box in Figure 3. The remaining reactions 
describe the regulation by uncharged tRNA molecules under 
starvation conditions.
The Dynamic Model
Based on this structural model, a dynamic model was programed 
in MATLAB. In that model, each interaction is characterized 
by a mathematical equation, thereby depicting a kinetic law 
to define the reaction rates. To describe the dynamics of the 
substrate concentrations, a system of ODE-System was built, 
TaBle 4 | calculated growth rates and generation times for 
DH5α-pcMV-lacZ.
Time point harvesting time 
point [h]
growth rate [h−1] generation time 
[min]
T1 8.17 0.305 136
T2 11.50 0.256 162
T3 17.50 0.090 347
These parameters are used in the described in silico analysis with the dynamic model, 
when the simulations begin at T1, T2, or T3. In these simulations, the simulation time 
corresponds to the generation time and the respective growth rate is used as a 
parameter in the rate equations.
TaBle 3 | calculated growth rates and generation times for DH5α-psUP 
201-3.
Time point harvesting time 
point [h]
growth rate [h−1] generation time 
[min]
T1 5.25 0.278 150
T2 8.25 0.302 138
T3 10.5 0.283 147
These parameters are used in the described in silico analysis with the dynamic model, 
when the simulations begin at T1, T2, or T3. In these simulations, the simulation time 
corresponds to the generation time and the respective growth rate is used as a 
parameter in the rate equations.
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which can be solved numerically, once the initial conditions are 
set. For replication control by RNAI and RNAII molecules with 
and without Rom protein, the rate equations recommended by 
Brendel and Perelson (1993) were used. As for the regulation by 
uncharged tRNA molecules, we propose kinetic equations based 
on mass action law. The corresponding parameters are assumed 
to be stable over time. Clearly, this assumption would not hold, if 
all growth phases were to be considered. Changing enzyme con-
centrations along with varying kinetic behavior would long for 
different models. As our area of interest is the exponential growth 
phase, we restrict our model to that time interval, within which 
the parameters stay constant. In vivo measurements of plasmid 
concentrations together with the appropriate growth rates and 
the RNAI and RNAII concentrations at different time points 
were incorporated in the dynamic model as initial conditions. 
The complete ODE-system along with the rate equations can be 
found in detail in the Supplementary Material.
results
cultivation and Determination of the growth 
rate for E. coli Dh5α carrying a low or a high 
copy Plasmid
Escherichia coli DH5α-pSUP 201-3 was cultivated in minimal 
medium and the optical densities of the culture were determined. 
These measurements were fitted with the Matlab function “poly-
fit,” which calculates the coefficient parameter set of polynomial 
coefficients with the lowest residual sum of squares. That is way, 
a polynomial equation with an order of four was obtained, which 
describes the bacterial growth for the strain carrying a low copy 
plasmid. Figure  1 presents the appropriate polynomial growth 
curve fit for E. coli DH5α-pSUP 201-3 together with the measured 
optical density values and the harvesting time points at which 
the RNAI, RNAII, and plasmid concentrations were measured. 
Additionally, the range of the highest and lowest OD600 values 
which were measured for each measuring time point is shown 
(Figure 1). In analogy to the low copy plasmid strain, the meas-
ured optical densities of the high copy strain were fitted with the 
MATLAB function “polyfit.” The resulting polynomial equation 
with an order of four describes the bacterial growth of E. coli 
DH5α-pCMV-lacZ (Figure 2). Comparing the measured optical 
density values with the best-fit curves (Figures 1 and 2), a very 
good description of the growth behavior for the low copy strain 
as well as for the high copy strain was obtained. To support this 
visual impression, χ2-tests were applied, which returned reduced 
χ2-values indicating the high fit quality. For both strains, the best-
fit curves are located very closely to the measured OD600 values 
and fit well into the area bounded by the highest and lowest OD600 
values measured between or at least very close to the minimal 
and maximal determined optical density curve throughout the 
whole exponential phase (Figures 1 and 2). During this period of 
cultivation, the theoretical model longs for the respective growth 
rates: the first derivative of the appropriate polynomial p gives 
the growth rate μ, for the respective harvesting time point. The 
calculated growth rates and the appropriate generation times are 
listed in Table 3 for E. coli DH5α-pSUP 201-3 and in Table 4 for 
DH5α-pCMV-lacZ.
Determination of the rnai/rnaii and the pDna 
concentrations
The RNAI and RNAII concentrations were determined for three 
different time points by qRT-PCR and the pDNA concentration 
was measured photometrically via NanoDrop and checked by 
agarose gel electrophoresis. This was carried out for the low copy 
strain, E. coli DH5α-pSUP 201-3, and for the high copy strain, 
E. coli DH5α-pCMV-lacZ, with three biological replicates. After 
qRT-PCR, the RNA concentrations were calculated by generating 
straight calibration lines from the RNAI and RNAII standards 
through linear regression. Regarding the results of E. coli DH5α-
pSUP 201-3, a decrease of the RNAI and RNAII concentrations 
with proceeding growth of the bacterial culture was observed 
(Table 5). Additionally, it was apparent that at every harvesting 
time point, there are always more free RNAI molecules than 
RNAII molecules in the cell. In contrast to the RNA concentra-
tions, the measured plasmid concentration per cell was stable 
over all three harvesting time points. PCNs of 46–48 were cal-
culated for each harvesting time point (Table 5). Regarding the 
determined PCNs of E. coli DH5α-pCMV-lacZ, an increase in 
plasmid concentrations with proceeding growth of the bacterial 
culture was observed (Table  6). For harvesting time point T1, 
a PCN of 1514 per cell was determined, while at T2 a PCN of 
2403 was found. At T3, 5805 plasmids per cell were measured. 
Cooper and Cass (2004) reported a PCN of 500–700 for pUC 
derivatives, so compared to the literature, the measured PCNs are 
very high. For this reason, we double checked the high magnitude 
of some of these values by qRT-PCR. The PCNs obtained by this 
analysis were in the same order of magnitude as the previously 
determined values. Considering the RNA concentrations per 
TaBle 6 | Measured rnai-, rnaii-, and plasmid concentrations for 
Dh5α-pcMV-lacZ at the three harvesting time points, depicted in 
Figure 2.
Time point rnai  
[molecules/cell]
rnaii  
[molecules/cell]
Pcn  
[molecules/cell]
T1 541 (±51) 22 (±2) 1514 (±1301)
T2 1086 (±298) 64 (±4) 2403 (±713)
T3 345 (±203) 75 (±10) 5806 (±4828)
TaBle 5 | Measured rnai-, rnaii-, and plasmid concentrations for 
Dh5α-psUP at the three harvesting time points, depicted in Figure 1.
Time point rnai  
[molecules/cell]
rnaii  
[molecules/cell]
Pcn  
[molecules/cell]
T1 34 (±7) 3 (±0.9) 46 (±26)
T2 17 (±5) 1 (±0.4) 48 (±30)
T3 6 (±0.7) 0.44 (±0.1) 46 (±17)
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cell, fluctuations in the RNAI concentrations were observed in 
contrast to measurements for E. coli DH5α-pSUP 201-3, while 
the RNAII concentrations increased with proceeding growth of 
the bacterial culture (Table 6). The highest RNAI concentration 
was measured at T2 with 1086 ± 298 RNAI molecules per cell and 
the highest RNAII concentration was found at T3 with 75 ± 10 
molecules per cell. If these RNA concentrations are compared to 
the RNA concentrations measured for E. coli DH5α-pSUP 201-3, 
it is apparent that at every harvesting time point, the amount of 
free RNAI and RNAII molecules in E. coli DH5α-pCMV-lacZ is 
higher than those in E. coli DH5α-pSUP 201-3.
For determination of the number of RNAI/RNAII molecules 
per cell as well as the PCN, the mean M (i =  1, 2, 3) for each 
biological replicate was calculated applying
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The structural Model of cole1-like Plasmid 
replication control
Using the CellDesigner software (Funahashi et  al., 2008), a 
structural model for the ColE1-like plasmid replication control 
was built (Figure 3). The involved elements and their interactions 
are given to describe the ColE1-like plasmid replication control 
in high- and low copy plasmids simultaneously. Three additional 
reactions make the difference between low copy plasmid replica-
tion control and high copy plasmid replication control. These 
reactions represent the control by the Rom protein and are marked 
with a red box in Figure 3. In case of a high copy plasmid replica-
tion, the control level by the Rom protein does not take place due 
to the deletion of the rom gene (Yanisch-Perron et al., 1985; Lin-
Chao et al., 1992). Since the model proposed in this study is an 
extension of the model presented by Brendel and Perelson (1993), 
the reactions which came from their model are marked by a blue 
box in Figure 3. The remaining reactions that were added in this 
study describe the regulation by uncharged tRNA molecules 
under starvation conditions. Regarding the replication control 
by uncharged tRNA molecules, there are two possibilities for the 
uncharged tRNA’s (tRNA) to act: the uncharged tRNA molecules 
can bind to plasmid bound RNAII molecules or they can bind 
to free RNAII molecules and afterwards build a complex with 
the pDNA. In both cases, the binding of the inhibitory RNAI 
molecules is prohibited and the elongation of the RNAII-primer 
can occur. According to Brendel and Perelson (1993, ) the syn-
thesis and degradation reactions of RNAI, RNAII, and the Rom 
protein were included. Since the model proposed in this study 
contains the regulatory level of uncharged tRNA molecules, it was 
necessary to add also the synthesis and degradation reactions of 
uncharged tRNA. These synthesis and degradation reactions are 
not shown in the structural model depicted in Figure 3, they are 
found in the Supplementary Material.
The plasmid replication depicted in Figure 3 starts with the 
transcription of a preprimer RNAII molecule from a region 
555 bp upstream of the origin of replication. This RNAII tran-
script has a length of 100–360  nt and persistently hybridizes 
with a region close to the origin of replication (pDNA–RNAII-s) 
(Tomizawa, 1986). At that step, there are three possible scenarios 
for the proceeding of the replication process: the first one is that 
a regulatory RNA molecule, named RNAI, binds to the hybrid-
ized RNAII molecule. The regulatory RNAI molecule is encoded 
on the opposite strand of that one on which RNAII is encoded. 
The synthesis of RNAI begins 445 nt upstream of the origin of 
replication and proceeds in the antisense direction compared to 
the RNAII synthesis. Since the antisense RNAI transcript is com-
plementary to RNAII, it is able to bind the plasmid-RNAII hybrid 
and forms a so-called kissing complex (pDNA–RNAII–RNAI 
unstable). When this transient complex is built, the elongation 
of RNAII is blocked (Tomizawa, 1986). The second scenario 
is that the hybridized RNAII molecule is elongated to a length 
>360 bp before an RNAI molecule could bind (pDNA-RNAII-
lo). In that case, RNAII is cleaved by an enzyme named RNase 
H. This enzyme releases the 3’OH group, so the modified RNAII 
molecule can act as a primer (pDNA–RNAII-Primer). In the fol-
lowing reaction, the RNAII-Primer will be elongated by the DNA 
polymerase I and the pDNA will be doubled (Itoh and Tomizawa, 
1980). As in the model of Brendel and Perelson (1993), we assume 
that the concentration and the activity of RNase H remain con-
stant. Additionally, it was assumed that RNAI, RNAII, the Rom 
protein, and uncharged tRNA molecules move freely through the 
cytoplasm.
The third scenario is the binding of a free uncharged tRNA 
to the plasmid bound RNAII (pDNA–RNAII–tRNA). When an 
uncharged tRNA is bound to RNAII, the RNAI molecules cannot 
bind anymore, but RNAII can still be cleaved and elongated and 
serves in this way as a primer (pDNA–RNAII-Primer) (Grabherr 
and Bayer, 2002). It is proposed in this model that not only 
plasmid bound RNAII can interact with an uncharged tRNA 
molecule but also free RNAII molecules can be bound by an 
uncharged tRNA (RNAII–tRNA). In that case, the RNAII–tRNA 
complex binds to the template DNA and a complex composed 
September 2015 | Volume 3 | Article 1279
Freudenau et al. Simulation of plasmid replication
Frontiers in Bioengineering and Biotechnology | www.frontiersin.org
of a plasmid, RNAII, and an uncharged tRNA molecule is built 
(pDNA–RNAII–tRNA). The RNAII molecule will be elongated 
and becomes a primer, so the plasmid replication starts. This third 
scenario was not considered in the model of Brendel and Perelson. 
Considering the case that the primer could not be formed because 
of binding of the RNAI molecule to the plasmid bound RNAII, 
an unstable complex between the plasmid, RNAII and RNAI 
is built (pDNA–RNAII–RNAI unstable). This complex could 
become stable, modeled by a rate equation with the rate constant 
k10 (Brendel and Perelson, 1993). Having a low copy plasmid, this 
unstable complex could be stabilized by the Rom protein. As pro-
posed in the model from Brendel and Perelson (1993), we assume 
that therefore the Rom protein binds to the unstable complex 
and builds a transient complex (pDNA–RNAII–RNAI–Rom). 
This transient complex then is converted into a stable complex 
between of plasmid, RNAII, and RNAI (pDNA–RNAII–RNAI 
stable). Since the Rom protein is not present in a high copy plas-
mid, the reactions with Rom participation are missing (Figure 3). 
In addition to the reactions presented in the structural model in 
Figure 3, we consider the synthesis and degradation reactions of 
RNAI, RNAII, uncharged tRNA, and of the Rom protein (Rom).
The Dynamic Model of cole1-like Plasmid 
replication control
In the dynamic model, the in vivo reaction kinetics of each inter-
action presented in the structural model (Figure 3) are described 
by applying mass action law kinetics. In addition to those reac-
tions shown in Figure 3, the reaction rates of the synthesis and 
degradation reactions of RNAI, RNAII, uncharged tRNA, and 
Rom protein were specified by mathematical equations. Due 
to the assumption that the kinetic parameters do not change 
through the exponential growth phase, they remain constant for 
every growth rate. The dynamics of the substrate concentrations 
are described by ODEs. In general, such an ODE reads as follows:
 
d S
dt
v v S[ ] = + + − ×[ ]1  n µ  (1)
with [S] representing the substrate concentration, vi (i = 1 … n) 
describing the involved reaction rates, t the time, and μ the specific 
growth rate. In every ODE a term, where the negative growth rate 
is multiplied with the substrate concentration (−μ …  [S]), was 
included. The application of the −μ … [S] term was proposed by 
Brendel and Perelson (1993) to account for the dilution effect due 
to cell growth. The dilution effect describes that the distribution 
of intracellular compounds to the daughter cell after cell division 
depends on the growth rate. In case of a fast growing cell, the 
intracellular volume will increase faster than the concentration 
of intracellular compounds. As a consequence, the daughter cell 
shows a lower concentration of intracellular compounds than the 
mother cell. A lower dilution effect was observed in slow growing 
cells. The reason for that is that a slow growing mother cell has 
more time to synthesize her intracellular compounds before it 
will divide into two daughter cells. Thus, the characteristics of 
the dilution effect depend on the growth rate. The ODE system is 
applied to simulate the regulation of ColE1-like plasmid replica-
tion. It was set up based on the structural model by applying mass 
action law together with the dilution term. The model implies 15 
metabolites (si = 1, … , 15) whose interactions are described by 26 
rate equations (vi = 1, … , 26) containing 26 kinetic constants ki. 
This means that all reactions visualized in the structural model by 
a reaction arrow are described mathematically by a rate equation 
(v1, … , v17). In addition to the visualized reactions in the struc-
tural model, synthesis and degradation reactions of Rom protein, 
RNAI/RNAII, and uncharged tRNA together with the reaction 
for complex formation of RNAI and RNAII are described by 
rate equations (v18, … ,v26). The model proposed in this work is a 
minimal model which includes the plasmid replication control by 
two regulatory RNA molecules (RNAI and RNAII), the control 
by Rom protein as well as the replication control by uncharged 
tRNA molecules. It comprises no reaction not involved in these 
levels of replication control. The mentioned 26 rate equations 
are necessary and sufficient to simulate the ColE1-like plasmid 
replication control, because they describe all relevant elements to 
investigate the proposed hypothesis.
The whole ODE-system and the 26 rate equations can be found 
in the supplement. The parameter values ki (i = 1, … , 26) used in 
the rate equations with the respective source are listed in Table 7. 
After defining all kinetic constants, the ODE-system could be 
solved numerically by applying a MATLAB solver. As initial 
conditions, the experimentally determined RNAI and RNAII 
concentrations together with 50% of the respective determined 
appropriate plasmid concentrations and the appropriate meas-
ured growth rates were used. The motivation for taking the half 
of the measured plasmid concentration value is the assumption 
that the measured plasmid concentration is equal to the plasmid 
concentration directly before cell division and that the pDNA will 
be doubled during one generation time. All unknown substrate 
concentrations were assigned the zero value, because it is assumed 
that the internal pool of these substances has to be synthesized 
and is comparatively low at the beginning of the investigation. 
Once the above-mentioned parameters and initial concentrations 
were included into the dynamic model, it was used for in silico 
analysis of the ColE1-like plasmid replication control.
simulations of the cole1-like Plasmid 
replication control – simulations for  
Parameter Fitting
Since some kinetic values are unknown so far, they had to be either 
estimated or determined via parameter fitting. To obtain reason-
able fits for the constants k3, k4, and k26 (Table 7), the experimentally 
determined data of harvesting time point T2 were used for the low 
copy plasmid as well as for the high copy plasmid. Obviously, this 
data set was not considered for later validation. In all simulations, 
one single cell was considered. The simulation time corresponds 
to the generation time, which was calculated using the respective 
growth rates determined for each harvesting time point. The 
simulations for parameter fitting and validation for DH5α-pSUP 
201-3 began at the particular harvesting time point and ran for the 
period of one cell duplication (i.e., simulation time = generation 
time), where one single cell was considered. Regarding the results 
for T3, for example, the simulation began at time point T3 and the 
simulation time was 147 min. In biological sense, this means that 
at T3 one single cell starts to grow, divides after 147 min and ends 
TaBle 9 | results of the in vitro and in silico determined Pcns for 
Dh5α-pcMV-lacZ.
Time point Measured pDna 
[molecules/cell]
simulated pDna 
[molecules/cell]
T1 1514 ± 1301 1718
T2 2403 ± 713 2405
T3 5806 ± 4828 5421
The in vitro determined PCNs are the results of the plasmid concentration 
measurements done by the Plasmid Factory (Bielefeld, Germany) and the in silico 
determined PCNs are calculated by the dynamic model. As initial conditions for the 
simulations, the experimentally determined data for the three harvesting time points T1, 
T2, and T3 were chosen. To these belong the measured RNAI-, RNAII-, and plasmid 
concentrations (Table 6) and the respective growth rates (Table 4). The simulation time 
was equal to the generation time (Table 4).
TaBle 8 | results of the in vitro and in silico determined Pcns for 
Dh5α-psUP.
Time point Measured pDna 
[molecules/cell]
simulated pDna 
[molecules/cell]
T1 46 ± 26 49
T2 48 ± 30 47
T3 46 ± 17 49
The in vitro determined PCNs are the results of the plasmid concentration 
measurements done by the Plasmid Factory (Bielefeld, Germany) and the in silico 
determined PCNs are calculated by the dynamic model. As initial conditions for the 
simulations, the experimentally determined data for the three harvesting time points T1, 
T2, and T3 were chosen. To these belong the measured RNAI-, RNAII-, and plasmid 
concentrations (Table 5) and the respective growth rates (Table 3). The simulation time 
was equal to the generation time (Table 3).
TaBle 7 | Parameter for in silico analysis of cole1-like plasmid 
replication control.
reaction 
kinetic
constant low copy 
plasmid
high copy 
plasmid
source
1 k1 [M−1·min−1] 1.7·108 Not available a,-
2 k2 [min−1] 0.17 Not available a,-
3 k3 [M−1·min−1] 1.02·108 3.05·106 c,c
4 k4 [min−1] 48 20 a,c
5 k5 [min−1] 12 12 a,a
6 k6 [min−1] 4.3 4.3 a,a
7 k7 [min−1] 3.8 4.19 f,f
8 k8 [min−1] 4.3 4.3 a,a
9 k9 [M−1· min−1] 0.25 0.25 a,a
10 k10 [min−1] 44 44 a,a
11 k11 [min−1] 0.085 0.085 a,a
12 k12 [min−1] 17 17 a,a
13 k13 [min−1] 34 Not available a,-
14 k14 [min−1] 1.8·105 1.8·105 b,b
15 k15 [M−1·min−1] 1.8·105 1.8·105 b,b
16 k16 [min−1] 12 12 g,g
17 k17 [min−1] 0.25 0.25 g,g
18 k18 [min−1] 6 6 a,a,d
19 k19 [min−1] 0.25 0.25 a,a,d
20 k20 [min−1] 4 Not available a,-
21 k21 [min−1] 0.35 0.35 a,a
22 k22 [min−1] 0.35 0.35 a,a
23 k23 [min−1] 0.14 Not available a,-
24 k24 [M·min−1] 7.99·10−6 7.99·10−6 e,e
25 k25 [M−1·min−1] 1.02·108 3.05·106 g,g
26 k26 [min−1] 0.35 0.35 c,c
-No literature data is found for this value.
aBrendel and Perelson (1993).
bWang et al. (2002) with the assumption that RNAII molecules are bound by tRNA 
molecules with the same kinetic constant like RNAI molecules bind to RNAII molecules 
in reaction 3.
cThis work (parameter fitting).
dk18 and k19 were calculated with an assumed RNA polymerase-transcription rate of 
50 nt s−1 (von Hippel et al., 1984).
ek24 was calculated with an assumed transcription rate of 42 nt s−1 [Gotta et al. (1991) 
and Klumpp (2011)].
fk7 was calculated with an assumed DNA-polymerase-elongation rate of 42 bp s−1 
(Alberts et al., 2007) under allowance of plasmid size.
gThis work (estimated).
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up with a PCN of 49, directly before the next cell division. 
The results of the parameter fitting and validation for E. coli 
DH5α-pSUP 201-3 are depicted in Table 8 in terms of simulated 
PCNs and experimentally determined PCNs. Besides the results 
assigned to time point T2, which can be regarded as the outcome 
of the fitting procedure, the simulation results for the remaining 
time points T1 and T3 meet the experimental outcome very well. 
These results were achieved without any additional fitting steps, 
just with the parameters determined for time point T2, which are 
summarized in Table 7 (fitted parameters are assigned the letter 
“c”). Comparing the simulated PCNs and the measured PCNs of E. 
coli DH5α-pSUP 201-3 and E. coli DH5α-pCMV-lacZ (Table 9), 
respectively, one can conclude that the dynamic model supplied 
with this data set can sufficiently explain the bacterial behavior for 
different cultivation time points. Comparing the simulated PCNs 
and the measured PCNs of E. coli DH5α-pSUP 201-3, it could 
be concluded that the dynamic model is able to reproduce the 
experimentally measured PCNs in an appropriate way. Looking 
at the simulated PCNs for E. coli DH5α-pCMV-lacZ, it could be 
observed that in this case the model is also able to reproduce the 
experimentally determined PCNs in an appropriate way (Table 9). 
The simulated PCNs reside within the margin represented by the 
SD. To sum up, the simulation of the plasmid replication control 
for all harvesting time points is possible and the model is able to 
reproduce the PCN in the requested correctness.
Predictive simulations
In this study, a dynamic model was developed to investigate the 
effect of uncharged tRNA molecules on the ColE1-like plasmid 
replication control. From this, the question arises if tRNA 
molecules can be modified in such a way that they cannot be 
charged any longer, and could we envisage an increase in plas-
mid production? In general, a high amount of uncharged tRNA 
molecules can be observed when the cell is afflicted with amino 
acid starvation. Under that condition, the protein synthesis is 
negatively affected and the majority of tRNA molecules in the 
cytoplasm are uncharged. Wróbel and Węgrzyn (1998) could 
show that a high amount of uncharged tRNA molecules is con-
nected with an increase in the PCN (Wróbel and Węgrzyn, 1998). 
Thus, for plasmid production, starvation conditions would be 
advantageous. There is just one single problem: for a long-term 
production process, these conditions are not applicable, because 
the cells will not survive until the plasmid production cultivation 
is finished. One possible solution could be the overexpression of a 
tRNA gene. But in that case, there is a certain probability that the 
higher amount of uncharged tRNA will be rapidly charged by the 
amino-acyl- tRNA synthetases before they could influence the 
FigUre 4 | simulation of the plasmid replication control for 
E. coli Dh5α-placZ, beginning at time point T3, for the following 
three different growth conditions: blue, growth with normal 
nutrient conditions; green, growth with amino acid starvation 
conditions, red, growth with modified trna gene without amino 
acid starvation conditions.
September 2015 | Volume 3 | Article 12711
Freudenau et al. Simulation of plasmid replication
Frontiers in Bioengineering and Biotechnology | www.frontiersin.org
plasmid replication. To overcome this problem, a modification of 
the tRNA molecule is required, which would preserve the charg-
ing and still positively influence the plasmid replication. In that 
case, the cell would be still vital under non-starvation conditions. 
But could such modified tRNA molecules actually push the plas-
mid replication? Therefore, the dynamic model was established, 
which enables to investigate how the plasmid replication control 
would behave, if a gene encoding a modified tRNA molecule was 
introduced into the genome.
To test the hypothesis that an uncharged tRNA would 
increase the PCN, the ColE1-like plasmid replication control of 
E. coli DH5α-pCMV-lacZ was simulated for the following three 
conditions: growth under normal nutrient conditions, growth 
under amino acid starvation conditions, and growth under the 
influence of an inserted gene encoding for a modified tRNA 
under normal nutrient conditions. E. coli DH5α-pCMV-lacZ was 
chosen, since for plasmid production usually high copy plasmids 
are used. The simulations could also be conducted for E. coli 
DH5α-pSUP 201-3, leading qualitatively to the same result (data 
not shown). The simulations were done for all three conditions, 
beginning at T3, for a period of one cell duplication [i.e., simula-
tion time = generation time (T3)]. One single cell is considered, 
which starts to grow at time point T3 and divides after 347 min. 
The initial conditions were the experimentally determined data 
at T3 (see Tables 4 and 6), which includes the RNAI- and RNAII 
concentrations together with half of the respective determined 
plasmid concentrations and the appropriate measured growth 
rate. All unknown substrate concentrations were assigned the 
value 0. This means that the simulations consider one single 
cell, which starts to grow at time point T3 and divides after 
347 min. In the moment of cell division, the simulation stops, 
so the daughter cells are not considered anymore. The time 
point T3 was chosen exemplarily, because at this time point 
the highest PCN was measured. Of course, it is possible to do 
these simulations just as well for T1 and T2. The simulation 
results of the three mentioned conditions are graphically shown 
in Figure  4. The first simulation (Figure  4) considers growth 
conditions with normal nutrient supply. To describe this situ-
ation mathematically, the kinetic constant of uncharged tRNA 
synthesis (k24) was multiplied with the factor 0.01 to keep the 
amount of free uncharged tRNA molecules very low, because the 
amino acids supply is sufficient, so the amount of free uncharged 
tRNA molecules is very low. The factor 0.01 was chosen due to 
the assumption that under sufficient nutrient supply, only 1% 
of the tRNA molecules in the cell are uncharged. The in  silico 
analysis showed that for a cell, growing under normal nutrient 
conditions, the PCN undergoes an increase to about 2523 (5421 
plasmids at T3  –  initial PCN =  2523). The second simulation 
(Figure 4) was done for a cell, which grows under amino acid 
starvation conditions. Here, the assumption was made, that as 
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a consequence of insufficient nutrient supply, the intracellular 
protein concentrations are decreased and so all reactions run 
with only 10% reaction velocity (estimated). Mathematically 
spoken, every kinetic constant and the growth rate were multi-
plied by the factor 0.1. Furthermore, the factor of 0.01 for k24 was 
replaced by 1, because of the high amount of uncharged tRNA 
molecules under amino acid starvation. The second simulation 
predicts that within a period of cell duplication, one single cell 
produces only 379 plasmids. In the third simulation (Figure 4), 
the cells grow under normal nutrient supply with a high amount 
of modified tRNA molecules, which were encoded by an inserted 
modified tRNA gene. As for the mathematical description, this 
means that all reactions are running at 100%, because there is 
no amino acid starvation. Furthermore, the factor 0.01 for the 
kinetic constant k24 was again replaced by 1, since there are a 
lot of free modified tRNA molecules in the cell. Under these 
conditions, the model predicts a plasmid production of 3822 
plasmids for one single cell within a period of cell duplication. 
Comparing all three simulations (Figure 4), it is apparent, that 
the plasmid production is lowest under insufficient nutrient 
supply. The highest plasmid production is predicted for the case 
when a gene, which encodes a modified, uncharged tRNA, is 
introduced into the genome.
Discussion
In the last 10 years, the number of clinical trials in the field of 
human gene therapy has increased from 500 to 1500 (Prazeres, 
2011). One can assume that once the clinical trials are completed 
and plasmid biopharmaceuticals enter the market, the demand 
of pDNA will increase. Since ColE1-type plasmids are often the 
basis for DNA vaccines or gene therapy products, it is important 
to understand how their replication is regulated (Prather et al., 
2003). The dynamic model presented here is a valuable contri-
bution to the modeling work done in this field, since it is more 
comprehensive than previous models (Ataai and Shuler, 1986; 
Bremer and Lin-Chao, 1986; Keasling and Palsson, 1989a,b; 
Brendel and Perelson, 1993; Wang et  al., 2002). It extends the 
model proposed by Brendel and Perelson (1993), because it does 
not only incorporate the regulation through inhibitory RNAI 
molecules, but it considers also the control by uncharged tRNA 
molecules. Some previous models have focused on the PCN 
deviation from steady states derived from RNAI and RNAII 
concentrations (Paulsson et al., 1998), plasmid stability or prob-
ability of plasmid loss (Paulsson and Ehrenberg, 1998), as well as 
the formation of stable RNAII structures (Gultyaev et al., 1995). 
However, the mentioned reports did not show the effect of RNAI, 
RNAII, or uncharged tRNA on PCN linked to cell growth. Thus, 
the underlying reaction network of the proposed model is more 
detailed and the number of application conditions is increased. 
The simulation data are confirmed by in  vitro measurements, 
obtained at three different time points. Since the data for each 
time point were measured for each time point in the same strain, 
they can be treated as homogeneous data sets. Many published 
dynamic models are based on heterogeneous data sets that consist 
of experimental data obtained from different strains and partly 
from different organisms (Klumpp, 2011). These heterogeneous 
data sets are not optimal for modeling, because usually the model 
should help to investigate a specific organism, so data measured 
in a foreign organism might be unsuitable. In comparison to 
other growth rate measurements both strains used in this work 
grow very slowly. This slow growth could be reasoned by the 
usage of minimal medium for cultivation, because it contains 
only essential additives. On LB-medium both strains show the 
typical growth behavior for E. coli DH5α.
The intracellular RNAI and RNAII concentrations were cal-
culated for E. coli DH5α-pSUP 201-3 and E. coli DH5α- pCMV-
lacZ via qRT-PCR with the aid of straight calibration lines. The 
intracellular RNAI- and RNAII concentrations measured for 
E. coli DH5α-pSUP 201-3 decrease with proceeding growth of 
the bacterial culture. Furthermore, it was observed that there 
are more free RNAI molecules than RNAII molecules at each 
harvesting time point. The RNA measurements of this study are 
similar to the RNAI- and RNAII measurements done by Brenner 
and Tomizawa (1991) 23  years ago. Brenner and Tomizawa 
(1991) quantified the RNAI and RNAII concentrations densito-
metrically for an E. coli C600 derivative (SA791) strain carrying 
a pCer plasmid or a pΔP4 plasmid (both low copy plasmids) 
applying quantitative probe protection experiments. They meas-
ured an average RNAII molecule number of 1.9 ± 0.9 to 3.7 ± 1.0 
per cell and an average RNAI molecule number of 333 ± 49 to 
499 ±  36 per cell (Brenner and Tomizawa, 1991). The RNAI 
concentrations determined by Brenner and Tomizawa (1991) 
are an order of 10 higher than the molecule numbers measured 
in this work. This could be reasoned by the different measuring 
methods. Possibly, the qRT-PCR is a more sensitive method 
compared to the quantification by quantitative probe protection 
experiments. Furthermore, Brenner and Tomizawa (1991) used 
a minimal medium supplemented with non-essential additives 
for cultivation, which could also have influenced the RNAI 
concentration. In comparison to E. coli DH5α-pSUP 201-3, 
the RNAI- and RNAII concentrations measured for E. coli 
DH5α- pCMV-lacZ do not decrease with proceeding growth of 
the bacterial culture. On the contrary, the intracellular RNAII 
concentrations increased with proceeding cultivation. Regarding 
the RNAI amount, the highest RNAI concentration was meas-
ured at time point T2 and the lowest at time point T3. Since there 
are no comparative values published so far, the measured RNA 
concentrations of E. coli DH5α-pCMV-lacZ cannot be compared 
with previously determined values. For E. coli DH5α-pSUP 
201-3, PCNs of 46 or 48 were measured at all three time points. 
The published PCNs for pBR322 plasmids are 15–20 plasmids 
per cell (Cooper and Cass, 2004), so the measured PCNs for E. 
coli DH5α-pSUP 201-3 are around two times higher. But con-
sidering the SDs of the measurements of this study, it could be 
seen that the PCNs measured by Cooper and Cass (2004) reside 
within the same range, defined by the SDs. Again the difference 
could be explained by the cultivation in minimal medium with 
no non-essential supplements used in this work, because the E. 
coli DH5α-pSUP 201-3-cells grew very slowly and a slow growth 
promotes the intracellular plasmid concentration (Bremer and 
Lin-Chao, 1986). Taken as a whole, the plasmid amount per cell 
of E. coli DH5α-pSUP 201-3 is stable within all three time points. 
In contrast to the low copy plasmid strain E. coli DH5α-pSUP 
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201-3, the plasmid concentration of E. coli DH5α-pCMV-lacZ 
increases with progressing growth of the bacterial culture. The 
highest plasmid concentration was measured at time point T3 
with 5806 ± 4828 plasmids per cell. It can be assumed that the 
increasing RNAII concentration is responsible for the increase of 
the PCN, because more RNAII molecules are available to serve 
as a primer. Comparing these measured PCNs with literature 
values shows that they are very high. For pUC plasmids, copy 
numbers of 500–700 were reported (Cooper and Cass, 2004). To 
address these differences, plasmid numbers were confirmed by 
qRT-PCR, resulting in the same order of magnitude. As for E. coli 
DH5α-pSUP 201-3, the minimal medium and the slow growth 
could be responsible for that high plasmid concentrations.
After the experimental data had been introduced to the 
dynamic model, the unknown parameters were partly obtained 
by parameter fitting. After comparing simulation results with 
our own experimental as well as literature data and achieving 
a satisfying validation, the model was ready to be used to do 
in silico analysis. The hypothesis that modified tRNA molecules 
would have a similar pushing effect on plasmid production like 
uncharged tRNA molecules have under starvation conditions was 
tested. The simulations showed that under amino acid starvation, 
the smallest amount of plasmids is produced. As for the effect 
of modified tRNA molecules on plasmid production, the model 
predicts an increase compared to the plasmid production under 
normal nutrient conditions. Thus, the insertion of a gene encoding 
modified uncharged tRNA molecules would have a positive effect 
on the plasmid production. Since the hypothesis is confirmed by 
in  silico analysis with the established model, the next step will 
be to concentrate on the design of a modified uncharged tRNA 
gene. This gene should encode for a modified tRNA molecule, 
which will not be recognized by an amino-acyl synthetase and 
therefore will not be charged anymore. Additionally, all elements 
influencing the ColE1-like plasmid replication control have to 
maintain functionality.
conclusion
In this study, a dynamic model of ColE1-like plasmid replica-
tion control for a low copy plasmid and a high copy plasmid 
was established. The model comprises the replication control by 
regulatory RNA molecules and by uncharged tRNA molecules. 
The big advantage of this model is that it is confirmed by in vitro 
measurements, which were done for the same strains and at 
three different time points. The established model was used to 
simulate the plasmid replication control for the period of one cell 
duplication, where one single cell was considered. Nevertheless, 
the model can also be used to predict the plasmid replication 
control for more than one period of cell duplication, which could 
be conducted for constant growth conditions as well as for vary-
ing growth conditions. The simulations done with the dynamic 
model within this work predict that inserting a gene encoding 
modified uncharged tRNA molecules would increase the PCN. 
Since the overall aim is to improve the plasmid production to 
accommodate the prospective demand on pDNA, this predicted 
effect of modified tRNA molecules is very important. For that 
reason, further investigation should be concentrated on the 
construction of such a modified uncharged tRNA gene.
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